{
    "organizations": [],
    "uuid": "4c933ea5731dea01de1825875ea40388e3a827bc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ligand-reports-q1-adjusted-earning/brief-ligand-reports-q1-adjusted-earnings-per-share-1-55-idUSASC0A0L1",
    "ord_in_thread": 0,
    "title": "BRIEF-Ligand Reports Q1 Adjusted Earnings Per Share $1.55",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Ligand Pharmaceuticals Inc:\n* Q1 REVENUE $56.2 MILLION * Q1 EARNINGS PER SHARE VIEW $1.15 — THOMSON REUTERS I/B/E/S\n* Q1 REVENUE VIEW $43 MILLION — THOMSON REUTERS I/B/E/S * FY2018 REVENUE VIEW $186.5 MILLION — THOMSON REUTERS I/B/E/S\n* WITH 2018 REVENUE GUIDANCE OF $184 MILLION, ADJUSTED EARNINGS PER DILUTED SHARE WOULD BE ABOUT $4.85\n* FY2018 EARNINGS PER SHARE VIEW $4.81 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T04:50:00.000+03:00",
    "crawled": "2018-05-09T12:54:26.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "ligand",
        "pharmaceutical",
        "inc",
        "q1",
        "revenue",
        "million",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "q1",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "fy2018",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "revenue",
        "guidance",
        "million",
        "adjusted",
        "earnings",
        "per",
        "diluted",
        "share",
        "would",
        "fy2018",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}